- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Zydus plans to launch an innovative Semaglutide Injection in India upon patent expiry. It features a novel reusable, adjustable single-pen device for Type 2 Diabetes & Obesity, enhancing patient adherence, convenience, and reducing therapy costs.